Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Cancer Therapeutics
  • View item
  • Home
  • ICR Divisions
  • Cancer Therapeutics
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Noncoding RNA in Cholangiocarcinoma.

Thumbnail
View/Open
Published version (352.0Kb)
Date
2019-02
ICR Author
Braconi, Chiara
Author
Salati, M
Braconi, C
Type
Journal Article
Metadata
Show full item record
Abstract
Cholangiocarcinomas (CCAs) are tumors with a dismal prognosis. Early diagnosis is a key challenge because of the lack of specific symptoms, and the curability rate is low due to the difficulty in achieving a radical resection and the intrinsic chemoresistance of CCA cells. Noncoding RNAs (ncRNAs) are transcripts that are not translated into proteins but exert their functional role by regulating the transcription and translation of other genes. The discovery of the first ncRNA dates back to 1993 when the microRNA (miRNA) lin-4 was discovered in Caenorhabditis elegans . Only 10 years later, miRNAs were shown to play an oncogenic role in cancer cells and within 20 years miRNA therapeutics were tested in humans. Here, the authors review the latest evidence for a role for ncRNAs in CCA and discuss the promise and challenges associated with the introduction of ncRNAs into clinical practice.
URI
https://repository.icr.ac.uk/handle/internal/3190
DOI
https://doi.org/10.1055/s-0038-1676097
Collections
  • Cancer Therapeutics
Subject
Humans
Cholangiocarcinoma
Bile Duct Neoplasms
Liver Neoplasms
MicroRNAs
Gene Expression Regulation, Neoplastic
Tumor Microenvironment
RNA, Long Noncoding
Carcinogenesis
Research team
Signal Transduction & Molecular Pharmacology
Language
eng
License start date
2019-02
Citation
Seminars in liver disease, 2019, 39 (1), pp. 13 - 25

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.